| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 223437-11-4 | 1-Butyl-1-methylpyrrolidinium bistriflimide | C9H20N.C2F6NO4S2 |
| 223463-13-6 | 5-Bromo-2-iodopyridine | C5H3BrIN |
| 223463-14-7 | 2-Bromopyridine-5-boronic acid | C5H5BBrNO2 |
| 223480-78-2 | 3-Methyl-2-pyridinesulfonic acid | C6H7NO3S |
| 223488-57-1 | CP-533536 | C25H28N2O5S |
| 223514-48-5 | 1-(5-Bromothiazol-2-yl)piperazine | C7H10BrN3S |
| 223519-11-7 | 3-Amino-5-bromo-4-methylbenzoic acid methyl ester | C9H10BrNO2 |
| 223532-02-3 | alpha-[[Hydroxy(2-phenylacetyl)amino]methyl]benzenepropanoic acid | C18H19NO4 |
| 223537-30-2 | Rupintrivir | C31H39FN4O7 |
| 223538-61-2 | (Z-DEVD)2-Rh 110 | C72H78N10O27 |
| 223555-84-8 | 1-(4-Bromophenyl)-N-ethylmethanesulfonamide | C9H12BrNO2S |
| 223555-85-9 | 1-(4-Bromophenyl)-N-propylmethanesulfonamide | C10H14BrNO2S |
| 223565-11-5 | 1,4-Bis(chloromethyl)-2,5-bis[(3,7-dimethyloctyl)oxy]benzene | C28H48Cl2O2 |
| 223568-55-6 | (3S)-5-Fluoro-3-[[(2S)-3-methyl-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]butyl]amino]-4-oxopentanoic acid | C18H23FN2O6 |
| 223569-28-6 | Poly(N,N'-bis(4-butylphenyl)-N,N'-diphenyl-1,4-benzenediamine-co-9,9-dioctylfluorene) | (C67H78N2)n |
| 223569-31-1 | Poly[(9,9-dioctylfluorenyl-2,7-diyl)-co-(4,4'-(N-(p-butylphenyl))diphenylamine)] | (C51H61N)n |
| 223570-85-2 | 2,3-Dihydropyrazolo[1,5,4-de]-1,4-benzoxazine-6-carboxylic acid (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester | C18H21N3O3 |
| 223572-88-1 | Paliocolor LC 756 | C50H46O20 |
| 223575-69-7 | 2-(Thiazol-2-yl)benzaldehyde | C10H7NOS |
| 223581-83-7 | (2S)-4-Oxo-1,2-pyrrolidinedicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester | C20H17NO5 |
| 223586-82-1 | Lurasidone Impurity A | C18H16N4S2 |
| 223595-17-3 | (1R)-5-Bromo-2,3-dihydro-1-methyl-1H-isoindole | C9H10BrN |
| 223595-19-5 | [(1R)-2,3-Dihydro-1-methyl-2-(triphenylmethyl)-1H-isoindol-5-yl]boronic acid | C28H26BNO2 |
| 223595-20-8 | (R)-5-(1,3,6,2-Dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline | C32H33BN2O2 |
| 223595-28-6 | 2,4-Dibromo-3-(difluoromethoxy)benzoic acid | C8H4Br2F2O3 |
| 223644-02-8 | Glanatec | C15H18FN3O2S.HCl |
| 223644-10-8 | (3R)-Hexahydro-3-methyl-1H-1,4-diazepine-1-carboxylic acid tert-butyl ester | C11H22N2O2 |
| 223645-67-8 | Ripasudil | C15H18FN3O2S |
| 223646-21-7 | Ethyl 2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | C10H10N2O3 |
| 223652-82-2 | Garenoxacin mesylate | C23H20F2N2O4.CH4O3S |
| 223652-90-2 | Garenoxacin mesylate hydrate | C23H20F2N2O4.CH4O3S.H2O |
| 223655-16-1 | Di-(tert-butyl)(ferrocenyl)phosphine | C18H27FeP |
| 223664-42-4 | 7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid | C13H7N3O5 |
| 223666-07-7 | Collagen proline hydroxylase inhibitor | C18H18N4O4 |
| 223668-09-5 | 4-Hydroxy-6-methoxy-1-methyl-2(1H)-quinolinone | C11H11NO3 |
| 223668-64-2 | Pentafluorophenyltrimethoxysilane | C9H9F5O3Si |
| 223668-68-6 | Bis(pentafluorophenyl)dimethoxysilane | C14H6F10O2Si |
| 223668-78-8 | Methoxytris(pentafluorophenyl)silane | C19H3F15OSi |
| 223671-15-6 | 7-Bromo-1(2H)-isoquinolinone | C9H6BrNO |
| 223671-53-2 | 1-Chloro-7-isoquinolinecarboxaldehyde | C10H6ClNO |
| 223671-54-3 | 1-Chloroisoquinoline-5-carboxylic acid hydrochloride | C10H6ClNO2.HCl |
| 223671-92-9 | 7-Isoquinolinecarbonitrile | C10H6N2 |
| 223673-34-5 | (alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol | C16H18N2O3 |
| 223673-36-7 | N-[2-(4-Aminophenyl)ethyl]-N-[(2R)-2-hydroxy-2-phenylethyl]carbamic acid tert-butyl ester | C21H28N2O3 |
| 223673-61-8 | Mirabegron | C21H24N4O2S |
| 223705-79-1 | Honey, 2-hydroxy-3-(trimethylammonio)propyl ethers, chlorides | |
| 223719-29-7 | 4,4',(5')-di(t-butyldicyclohexano)-18-crown-6 | C28H52O6 |
| 223734-57-4 | (6S)-1-[3-methoxy-2-(2-propen-1-yl)phenyl]-6-[(tetrahydro-2H-pyran-2-yl)oxy]-2-Undecyn-1-one | C26H36O4 |
| 223734-62-1 | (S)-5-[(Tetrahydropyranyl)oxy]-1-decyne | C15H26O2 |
| 223735-62-4 | N,N,N',N'-Tetrakis(4-methylphenyl)-[9,9'-bianthracene]-10,10'-diamine | C56H44N2 |